SSRIs are linked to a condition called neonatal adaption syndrome, in which infants are born jittery, irritable and with abnormal muscle tone. About one-third of infants born to mothers taking SSRIs ...

Glenmark’s backlogged testing “was overdue by 3 months or longer for a large proportion of your samples,” the FDA wrote in ...

Recent health headlines include FDA's eye safety concerns over GSK's cancer drug, escalating malnutrition rates in Gaza reported by the UN, and notable healthcare IPO success stories from Morocco and ...

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15 Provided by GlobeNewswire Jul 16, 2025, 5:45:00 AM ...

The FDA is reevaluating GlaxoSmithKline’s blood cancer drug Blenrep following mixed results from two phase 3 trials and mounting concerns about eye-related side effects and dosing. The agency is ...

GSK (GSK) stock in focus as the FDA staff raise safety concerns over Blenrep combo for multiple myeloma ahead of an AdCom meeting. Read more here.

Crime Major drug bust leads to questions of safety in downtown Louisville In both federal and local drug busts, authorities express their focus to make the city safer.

‘General Hospital' Says Goodbye to Eva LaRue More Than 140,000 Pounds of Lunch Meat Recalled Nationwide—Check Your Fridge Now What's the Best Exercise to Lower Heart Attack Risk? The No. 1 ...

The patient also developed delayed immune-related adrenal insufficiency, raising questions about the drug’s immunomodulatory effects. This case supports further investigation into the efficacy and ...

DeKalb County police say a June 19 raid on a Scottdale home was connected to a larger drug trafficking investigation that yielded four arrests.

FDA raised safety concerns for Vyvgart Hytrulo in CIDP, while Argenx moves ARGX-119 into late-stage trials for rare neuromuscular disease.